C07D 231/12
With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to
Official title: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D231/12 (With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to) appears on 5,666 US grants and 3,282 published applications in this corpus.
Search patents in C07D- Granted patents
- 5,666
- Published applications
- 3,282
- Assignees
- 1,470
- Inventors
- 12,653
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 55 | 0 |
| 1977 | 44 | 0 |
| 1978 | 59 | 0 |
| 1979 | 51 | 0 |
| 1980 | 83 | 0 |
| 1981 | 67 | 0 |
| 1982 | 81 | 0 |
| 1983 | 77 | 0 |
| 1984 | 85 | 0 |
| 1985 | 130 | 0 |
| 1986 | 144 | 0 |
| 1987 | 117 | 0 |
| 1988 | 142 | 0 |
| 1989 | 184 | 0 |
| 1990 | 202 | 0 |
| 1991 | 175 | 0 |
| 1992 | 184 | 0 |
| 1993 | 166 | 0 |
| 1994 | 126 | 0 |
| 1995 | 130 | 0 |
| 1996 | 151 | 0 |
| 1997 | 171 | 0 |
| 1998 | 156 | 0 |
| 1999 | 167 | 0 |
| 2000 | 149 | 0 |
| 2001 | 141 | 30 |
| 2002 | 191 | 163 |
| 2003 | 171 | 238 |
| 2004 | 115 | 274 |
| 2005 | 118 | 190 |
| 2006 | 147 | 154 |
| 2007 | 121 | 160 |
| 2008 | 98 | 122 |
| 2009 | 91 | 145 |
| 2010 | 99 | 157 |
| 2011 | 93 | 115 |
| 2012 | 103 | 110 |
| 2013 | 100 | 110 |
| 2014 | 114 | 115 |
| 2015 | 90 | 116 |
| 2016 | 94 | 137 |
| 2017 | 104 | 127 |
| 2018 | 99 | 106 |
| 2019 | 79 | 94 |
| 2020 | 87 | 125 |
| 2021 | 75 | 101 |
| 2022 | 69 | 89 |
| 2023 | 57 | 99 |
| 2024 | 50 | 75 |
| 2025 | 37 | 82 |
| 2026 | 27 | 48 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- PAI-1 inhibitors and uses thereof15 Sep 2026US 12,735,402 B2The Cleveland Clinic Foundation
- Inhibitors of interleukin-1 receptor-associated kinases 1 and 411 Aug 2026US 12,703,698 B2University of Rochester
- Compound and method for preventing or treating of respiratory diseases comprising the same as an active ingredient28 Jul 2026US 12,691,101 B2Yonsei University, University—Industry Foundation (Uif)
- Method for preparing porous aromatic framework membranes based on inorganic salt template method7 Jul 2026US 12,673,297 B2
- Prodrugs of myc inhibitors8 Oct 2026US 2026/0308129 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Inhibitors of myc and uses thereof17 Sep 2026US 2026/0274827 A1Northwestern University
- Aromatic compounds for use as protein phosphatase 2a (pp2a) modulators10 Sep 2026US 2026/0265190 A1Rappta Therapeutics Oy
- Tetraline, phenylcyclobutane and phenylcyclopentane analogs as rxfp1 agonists10 Sep 2026US 2026/0265208 A1Bristol-Myers Squibb Company
Most cited
By later US patents
- Phenyl and fluorenyl substituted phenyl-pyrazole complexes of Ir897US 7,338,722 B2University of Southern California · 2008
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Alkynyl and azido-substituted 4-anilinoquinazolines379US 5,747,498 APfizer Inc. · 1998
- Method for deuteration of a heterocyclic ring304US 7,517,990 B2Wako Pure Chemical Industries, Ltd. · 2009
- Substituted biphenyl isoxazole sulfonamides222US 5,612,359 ABristol-Myers Squibb Company · 1997